MGMT-METHYLATED GLIOBLASTOMA

Clinical trials for MGMT-METHYLATED GLIOBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new MGMT-METHYLATED GLIOBLASTOMA trials appear

Sign up with your email to follow new studies for MGMT-METHYLATED GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 1 Completed 1

New hope for fighting back against aggressive brain tumors

Disease control Terminated

This study is testing whether adding a new drug called selinexor to standard chemotherapy (temozolomide) works better than the standard chemotherapy alone for glioblastoma brain cancer that has returned. The trial first finds the safest dose of the combination, then compares how …

Matched conditions: MGMT-METHYLATED GLIOBLASTOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

MGMT-METHYLATED GLIOBLASTOMA

Get alerted when new MGMT-METHYLATED GLIOBLASTOMA trials appear

New hope for fighting back against aggressive brain tumors